Skip to main content

Table 3 The distribution of LRR by intrinsic molecular subtype

From: Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy

Molecular Subtypes

Total No.

LRR

CW

SCN

Axilla

IMN

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

Luminal A

2397

105 (4.4)

47 (44.8)

50 (47.6)

20 (19.0)

9 (8.6)

Luminal B-Her2 negative

573

42 (7.3)

24 (57.1)

23 (54.8)

11 (26.2)

7 (16.7)

Luminal B-Her2 positive

810

58 (7.2)

25 (43.1)

30 (51.7)

13 (22.4)

6 (10.3)

Her2-enriched

583

50 (8.6)

23 (46.0)

32 (64.0)

8 (16.0)

7 (14.0)

Triple-negative

967

100 (10.3)

58 (58.0)

50 (50.0)

21 (21.0)

12 (12.0)

Total cohort

5330

355 (6.7)

177 (49.9)

185 (52.1)

73 (20.6)

41 (11.5)